Atlas Trials

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Clinical trial NCT01213979 · COMPLETED

Trial details

NCT number
NCT01213979
Sponsor
Pharmacosmos A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-hematological Malignancies
Start date
2012-02-01
Primary completion
2012-05-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.